BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18805793)

  • 1. Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination.
    Isono O; Ohshima T; Saeki Y; Matsumoto J; Hijikata M; Tanaka K; Shimotohno K
    J Biol Chem; 2008 Dec; 283(49):34273-82. PubMed ID: 18805793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.
    Basbous J; Arpin C; Gaudray G; Piechaczyk M; Devaux C; Mesnard JM
    J Biol Chem; 2003 Oct; 278(44):43620-7. PubMed ID: 12937177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.
    Matsumoto J; Ohshima T; Isono O; Shimotohno K
    Oncogene; 2005 Feb; 24(6):1001-10. PubMed ID: 15592508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
    Satou Y; Yasunaga J; Yoshida M; Matsuoka M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-1 basic leucine-zipper factor, HBZ, interacts with MafB and suppresses transcription through a Maf recognition element.
    Ohshima T; Mukai R; Nakahara N; Matsumoto J; Isono O; Kobayashi Y; Takahashi S; Shimotohno K
    J Cell Biochem; 2010 Sep; 111(1):187-94. PubMed ID: 20506502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.
    Arnold J; Yamamoto B; Li M; Phipps AJ; Younis I; Lairmore MD; Green PL
    Blood; 2006 May; 107(10):3976-82. PubMed ID: 16424388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1 viral oncoprotein HBZ contributes to the enhancement of HAX-1 stability by impairing the ubiquitination pathway.
    Tanaka Y; Mukai R; Ohshima T
    J Cell Physiol; 2021 Apr; 236(4):2756-2766. PubMed ID: 32893878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB.
    Zhao T; Yasunaga J; Satou Y; Nakao M; Takahashi M; Fujii M; Matsuoka M
    Blood; 2009 Mar; 113(12):2755-64. PubMed ID: 19064727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity for HBZ-SP1 isoform of HTLV-I to inhibit c-Jun activity correlates with sequestration of c-Jun into nuclear bodies rather than inhibition of its DNA-binding activity.
    Clerc I; Hivin P; Rubbo PA; Lemasson I; Barbeau B; Mesnard JM
    Virology; 2009 Sep; 391(2):195-202. PubMed ID: 19595408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-1 HBZ positively regulates the mTOR signaling pathway via inhibition of GADD34 activity in the cytoplasm.
    Mukai R; Ohshima T
    Oncogene; 2014 May; 33(18):2317-28. PubMed ID: 23708656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.
    Larocque É; André-Arpin C; Borowiak M; Lemay G; Switzer WM; Duc Dodon M; Mesnard JM; Barbeau B
    J Virol; 2014 Aug; 88(16):8956-70. PubMed ID: 24872589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies.
    Hivin P; Basbous J; Raymond F; Henaff D; Arpin-André C; Robert-Hebmann V; Barbeau B; Mesnard JM
    Retrovirology; 2007 Feb; 4():14. PubMed ID: 17306025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
    Cook PR; Polakowski N; Lemasson I
    J Mol Biol; 2011 Jun; 409(3):384-98. PubMed ID: 21497608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.
    Murata K; Hayashibara T; Sugahara K; Uemura A; Yamaguchi T; Harasawa H; Hasegawa H; Tsuruda K; Okazaki T; Koji T; Miyanishi T; Yamada Y; Kamihira S
    J Virol; 2006 Mar; 80(5):2495-505. PubMed ID: 16474156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.
    Lemasson I; Lewis MR; Polakowski N; Hivin P; Cavanagh MH; Thébault S; Barbeau B; Nyborg JK; Mesnard JM
    J Virol; 2007 Feb; 81(4):1543-53. PubMed ID: 17151132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The splice 1 variant of HTLV-1 bZIP factor stabilizes c-Jun.
    Polakowski N; Pearce M; Kuguyo O; Boateng G; Hoang K; Lemasson I
    Virology; 2020 Oct; 549():51-58. PubMed ID: 32841759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.
    Rushing AW; Hoang K; Polakowski N; Lemasson I
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HTLV-1 HBZ protein inhibits cyclin D1 expression through interacting with the cellular transcription factor CREB.
    Ma Y; Zheng S; Wang Y; Zang W; Li M; Wang N; Li P; Jin J; Dong Z; Zhao G
    Mol Biol Rep; 2013 Oct; 40(10):5967-75. PubMed ID: 24065533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
    Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HBZ gene, a key player in HTLV-1 pathogenesis.
    Matsuoka M; Green PL
    Retrovirology; 2009 Aug; 6():71. PubMed ID: 19650892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.